FMC to Explore Strategic Alternatives Including Possible Sale

Dow Jones

02/05

By Kelly Cloonan

FMC plans to explore strategic options for the company, including a potential sale.

The agricultural sciences company said Wednesday the strategic review is at a preliminary stage, and it cannot be certain that any transaction will occur.

FMC continues to focus on strengthening its balance sheet by paying down $1 billion in debt through asset sales and licensing agreements, the company said, including the sale of its commercial business in India.

The company is also working to improve the competitiveness of its legacy core portfolio and manage its Rynaxypyr product after its patent expired. It will also continue advancing commercialization for new active ingredients.

The company said it believes additional investment in its four new active ingredients might accelerate growth and improve its results.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

February 04, 2026 17:33 ET (22:33 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2609311384"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609311384\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609311384?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 06:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609311384","market":"us","top_or_hot":-1,"title":"FMC to Explore Strategic Alternatives Including Possible Sale","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  FMC plans to explore strategic options for the company, including a potential sale. \n</p>\n<p>\n  The agricultural sciences company said Wednesday the strategic review is at a preliminary stage, and it cannot be certain that any transaction will occur. \n</p>\n<p>\n  FMC continues to focus on strengthening its balance sheet by paying down $1 billion in debt through asset sales and licensing agreements, the company said, including the sale of its commercial business in India. \n</p>\n<p>\n  The company is also working to improve the competitiveness of its legacy core portfolio and manage its Rynaxypyr product after its patent expired. It will also continue advancing commercialization for new active ingredients. \n</p>\n<p>\n  The company said it believes additional investment in its four new active ingredients might accelerate growth and improve its results. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 17:33 ET (22:33 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FMC to Explore Strategic Alternatives Including Possible Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFMC to Explore Strategic Alternatives Including Possible Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-05 06:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  FMC plans to explore strategic options for the company, including a potential sale. \n</p>\n<p>\n  The agricultural sciences company said Wednesday the strategic review is at a preliminary stage, and it cannot be certain that any transaction will occur. \n</p>\n<p>\n  FMC continues to focus on strengthening its balance sheet by paying down $1 billion in debt through asset sales and licensing agreements, the company said, including the sale of its commercial business in India. \n</p>\n<p>\n  The company is also working to improve the competitiveness of its legacy core portfolio and manage its Rynaxypyr product after its patent expired. It will also continue advancing commercialization for new active ingredients. \n</p>\n<p>\n  The company said it believes additional investment in its four new active ingredients might accelerate growth and improve its results. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 17:33 ET (22:33 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0471298777.SGD","symbol_name":"Blackrock Nutrition A2 SGD-H","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2609311384","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609311384","pubTimestamp":1770244380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"FMC plans to explore strategic options for the company, including a potential sale.The agricultural sciences company said Wednesday the strategic review is at a preliminary stage, and it cannot be certain that any transaction will occur.FMC continues to focus on strengthening its balance sheet by paying down $1 billion in debt through asset sales and licensing agreements, the company said, including the sale of its commercial business in India.The company is also working to improve the competitiveness of its legacy core portfolio and manage its Rynaxypyr product after its patent expired. It will also continue advancing commercialization for new active ingredients.The company said it believes additional investment in its four new active ingredients might accelerate growth and improve its results.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","BK4093":"化肥与农用药剂","BK4588":"碎股","LU0385154629.USD":"贝莱德营养科学基金A2","BK4585":"ETF&股票定投概念","FMC":"FMC Corp.","BK4545":"锂电池"},"translate_title":"FMC将探索战略替代方案，包括可能的出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FMC":1.5},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  FMC plans to explore strategic options for the company, including a potential sale. \n\n\n  The agricultural sciences company said Wednesday the strategic review is at a preliminary stage, and it cannot be certain that any transaction will occur. \n\n\n  FMC continues to focus on strengthening its balance sheet by paying down $1 billion in debt through asset sales and licensing agreements, the company said, including the sale of its commercial business in India. \n\n\n  The company is also working to improve the competitiveness of its legacy core portfolio and manage its Rynaxypyr product after its patent expired. It will also continue advancing commercialization for new active ingredients. \n\n\n  The company said it believes additional investment in its four new active ingredients might accelerate growth and improve its results. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 17:33 ET (22:33 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}